Hepatitis C Infection and Chronic Renal Diseases

Overview

Journal Hepatol Int

Publisher Springer

Specialty Gastroenterology

Date 2015 Jul 24

PMID 26201619

Authors

Aline Gonzalez Vigani

Affiliations

Soon will be listed here.

Abstract

Hepatitis C virus (HCV) infection and chronic renal diseases can be linked in two different ways. Some forms of renal disease are precipitated by HCV infection, while patients with end-stage renal disease are at increased risk for acquiring HCV infection. Patients with chronic HCV infection and renal disease have a poor prognosis. Most studies on treatment of HCV and renal diseases have been uncontrolled trials with small number of subjects. So, there is a lack of evidence-based recommendations and guidelines on the management of this condition. In this review, we will attempt to provide the most recent insights on HCV infection both as a extrahepatic manifestations and as a complication of end-stage renal patients.

References

Ozdogan M, Ozgur O, Boyacioglu S, Coskun M, Kart H, Ozdal S . Percutaneous liver biopsy complications in patients with chronic renal failure. Nephron. 1996; 74(2):442-3. DOI: 10.1159/000189358. View

Lake J . The role of immunosuppression in recurrence of hepatitis C. Liver Transpl. 2003; 9(11):S63-6. DOI: 10.1053/jlts.2003.50264. View

Maylin S, Martinot-Peignoux M, Moucari R, Boyer N, Ripault M, Cazals-Hatem D . Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology. 2008; 135(3):821-9. DOI: 10.1053/j.gastro.2008.05.044. View

Nagasaka A, Takahashi T, Sasaki T, Takimoto K, Miyashita K, Nakamura M . Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: host genetic and virological study. J Med Virol. 2001; 65(1):52-7. View

Tang S, Lai K . Chronic viral hepatitis in hemodialysis patients. Hemodial Int. 2005; 9(2):169-79. DOI: 10.1111/j.1492-7535.2005.01129.x. View

Okuda K, Hayashi H, Yokozeki K, Irie Y . Destruction of hepatitis C virus particles by haemodialysis. Lancet. 1996; 347(9005):909-10. DOI: 10.1016/s0140-6736(96)91397-5. View

Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C . Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology. 1998; 29(1):257-63. DOI: 10.1002/hep.510290123. View

Ferri C, Moriconi L, Gremignai G, Migliorini P, Paleologo G, FOSELLA P . Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron. 1986; 43(4):246-53. DOI: 10.1159/000183849. View

De Vecchi A, Montagnino G, Pozzi C, Tarantino A, Locatelli F, Ponticelli C . Intravenous methylprednisolone pulse therapy in essential mixed cryoglobulinemia nephropathy. Clin Nephrol. 1983; 19(5):221-7. View

10.

Bruchfeld A, Lindahl K, Stahle L, Soderberg M, Schvarcz R . Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant. 2003; 18(8):1573-80. DOI: 10.1093/ndt/gfg209. View

11.

Bestard O, Cruzado J, Ercilla G, Goma M, Torras J, Seron D . Rituximab induces regression of hepatitis C virus-related membranoproliferative glomerulonephritis in a renal allograft. Nephrol Dial Transplant. 2006; 21(8):2320-4. DOI: 10.1093/ndt/gfl266. View

12.

Rocha C, Perez R, Ferreira A, Carvalho-Filho R, Pace F, Silva I . Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis. Liver Int. 2006; 26(3):305-10. DOI: 10.1111/j.1478-3231.2005.01225.x. View

13.

Hanrotel C, Toupance O, Lavaud S, Thiefin G, Brodard V, Ingrand D . Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C. Nephron. 2001; 88(2):120-6. DOI: 10.1159/000045971. View

14.

Fissell R, Bragg-Gresham J, Woods J, Jadoul M, Gillespie B, Hedderwick S . Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004; 65(6):2335-42. DOI: 10.1111/j.1523-1755.2004.00649.x. View

15.

Singer D, Venning M, Lockwood C, Pusey C . Cryoglobulinaemia: clinical features and response to treatment. Ann Med Interne (Paris). 1986; 137(3):251-3. View

16.

Fabrizi F, Dixit V, Messa P, MARTIN P . Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials. J Viral Hepat. 2008; 15(2):79-88. DOI: 10.1111/j.1365-2893.2007.00907.x. View

17.

Fabrizi F, Colucci P, Ponticelli C, Locatelli F . Kidney and liver involvement in cryoglobulinemia. Semin Nephrol. 2002; 22(4):309-18. View

18.

McHutchison J, Gordon S, Schiff E, Shiffman M, Lee W, Rustgi V . Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med. 1998; 339(21):1485-92. DOI: 10.1056/NEJM199811193392101. View

19.

Hadziyannis S, Sette Jr H, Morgan T, Balan V, Diago M, Marcellin P . Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004; 140(5):346-55. DOI: 10.7326/0003-4819-140-5-200403020-00010. View

20.

Hanuka N, Sikuler E, Tovbin D, Mostoslavsky M, Hausman M, Orgel M . Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies. J Viral Hepat. 2002; 9(2):141-5. DOI: 10.1046/j.1365-2893.2002.00332.x. View